QA: Endo International plc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001593034_2023_Endo_International_plc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001593034, Endo International plc

  xvar xval
0 AssetsCurrent 2,076,768,000
1 IntangibleAssetsNetIncludingGoodwill 3,084,946,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 596,223,000
4 LiabilitiesCurrent 689,627,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,092,499,000
8 SellingGeneralAndAdministrativeExpense 777,169,000
9 ResearchAndDevelopmentExpense 128,033,000
10 remainder_Expenses 2,786,124,000
11 remainder_Revenues 2,318,875,000
12 remainder_NetIncome -458,155,000
13 remainder_ComprehensiveNetIncome -10,496,000
  yvar yval
0 Assets 5,757,937,000
1 Liabilities 689,627,000
2 Expenses 4,783,825,000
3 Revenues 2,318,875,000
4 StockholdersEquity 5,068,310,000
5 NetIncome -2,923,105,000
6 ComprehensiveNetIncome -2,928,353,000
7 BaseVar 7,009,457,500
8 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution

Change over Time